一个传感器控制的数字游戏的心脏衰竭自我照顾基于行为变化框架.
Kavita Radhakrishnan1, Atami Sagna DeMain1, Christine Julien2
1School of Nursing, The University of Texas-Austin, Austin, USA.
概括
数字游戏可以激励心力衰竭患者进行自我护理活动. 这项研究详细介绍了一款由传感器控制的数字游戏 (SCDG),旨在提高患者的参与度和坚持重要的健康行为.
科学领域:
- 数字健康干预措施 数字健康干预措施
- 患者参与策略 患者参与策略
- 心力衰竭管理心力衰竭管理
背景情况:
- 自我照顾对于管理心力衰竭至关重要,但往往由于知识或动机不足而受到阻碍.
- 传统的患者教育方法可能没有足够地让个人参与到关键的自我护理行为中.
研究的目的:
- 为心力衰竭自我护理引入一种新的传感器控制数字游戏 (SCDG).
- 描述一个增强的SCDG代的设计和开发.
主要方法:
- 开发一种传感器控制的数字游戏 (SCDG),其中游戏与现实世界的自我护理行动相联系.
- 代设计过程,包括游戏测试反和行为理论.
主要成果:
- 该SCDG旨在增强自我护理行为的动机和知识,如身体活动和体重监测.
- 游戏测试结果为基于用户交互和参与模式的SCDG的改进提供了信息.
结论:
- 传感器控制的数字游戏为改善心力衰竭自我护理提供了一个有希望的途径.
- 代开发方法确保SCDG与行为科学原则保持一致,以最大限度地影响患者.
相关概念视频
Heart Failure VII: Nursing Interventions
85
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
85
Heart Failure V: Medical Management
10
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
10
Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
Cardiomyopathy V: Interprofessional Care
14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Heart Failure I: Introduction
14
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
14
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
441
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
441


